FDA grants Infant Bacterial Therapeutics Type B pre-BLA meeting request
FDA granted Infant Bacterial Therapeutics AB’s request for a Type B pre-BLA meeting to discuss its BLA preparation. The meeting is scheduled for October 29, 2026, in Washington.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
FDA granted Infant Bacterial Therapeutics AB’s request for a Type B pre-BLA meeting to discuss its BLA preparation. The meeting is scheduled for October 29, 2026, in Washington.